Failings in the prevention, diagnoses and treatment of lung diseases are “silently suffocating” the health service and ...

A staggering 89% of TB patients in the Big Apple are foreign-born. The Flushing/Clearview areas of Queens, Sunset Park, Brooklyn and the Lower East Side of Manhattan are the neighbourhoods most ...

Just living with a smoker increases your chance of developing lung cancer or heart disease from secondhand smoke by as much as 30 percent. All told, smoking and exposure to tobacco smoke cause about ...

Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for pulmonary diseases, particularly pulmonary arterial hypertension (PAH) and pulmonary hypertension ...

These compelling results support advancing the development of nintedanib DPI for patients living with IPF, a chronic and progressive fibrotic lung disease with limited treatment options,” said Michael ...

Two Indiana University doctors have been awarded grants by the American Lung Association Research Institute for their ...

RILD in NHL patients presents as lung disease, organizing pneumonia, and nonspecific interstitial pneumonia, with 179 ...

Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and ...

In operable non-small cell lung cancer (NSCLC), molecular residual disease (MRD) detection via circulating tumor DNA (ctDNA) ...

50 – 80 years of age Have a 20 pack-year history of smoking (1 pack a day for 20 years or 2 packs a day for 10 years) Are a current smoker or have quit within the last 15 years If you meet the ...

Third Quarter 2024 and Subsequent Period Highlights Third Quarter 2024 Financial Highlights and Cash Position About Efzofitimod Efzofitimod is a first-in-class biologic immunomodulator in clinical ...

The following is a summary of “A modified Delphi exercise in physician-perceived risk factors for drug-induced pneumotoxicity ...